Does the use of 10 contemporary biomarkers improve the prediction of first major cardiovascular events and death compared to standard risk factors?
Adding 10 contemporary biomarkers to standard risk factors provides only moderate incremental value for predicting first major cardiovascular events and death.
For assessing risk in individual persons, the use of the 10 contemporary biomarkers that we studied adds only moderately to standard risk factors.
Wang et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: